Haematology conferences | world haematology 2019 | oncology conferences | haematology 2019 | haematology conferences 2019 | Haematology congress | Asia pacific | USA | Europe

Theme: Contemporary researches in Hematology and Oncology

World Hematology 2019

World Hematology 2019

Conference Series organizes a conferences of 3000+ Global Events inclusive of 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members.

Conference Series LLC LTD invites all the participants across the globe to attend the “Contemporary researches in Haematology and Oncology”

13th World Congress on Haematology and Oncology" (World Haematology 2019) conveys recent discoveries and developments in blood disorders and cancers. A complete knowledge of a scientific discipline that described and explores the use of testing, extraction and Devices in industry as well as healthcare markets.

World Haematology 2019 provides the importance of Blood and Disorders. Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (hemostasis and thrombosis). A hematologist is a medical doctor who applies this specialized knowledge to treat patients with blood conditions. Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet. People may be affected by many different types of blood conditions and blood cancers. Common blood disorders include anemia, bleeding disorders such as hemophilia, blood clots, and blood cancers such as leukemia, lymphoma, and myeloma.

Approximately every 3 minutes one person is diagnosed with a blood cancer. An estimated combined total of 174,250 people are expected to be diagnosed with leukemia, lymphoma or myeloma in 2018. New cases of leukemia, lymphoma and myeloma are expected to account for 10 percent of the estimated 1,735,350 new cancer cases diagnosed in the in 2018.

Highlights:

150+ Participation (60 Industry: 40 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
5+ Exhibitors
19 Innovative Educational Sessions
5+ Workshops
B2B Meetings

Track 1: Haematology

Hematology is the part of pharmaceutical worried about the investigation, conclusion, treatment, and anticipation of illnesses identified with the blood. It includes diagnosing and further administration of ailments that influence the creation of blood and its segments, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the system of coagulation. A couple of these diverse kinds of blood conditions that are taken a gander at incorporate pallor, thalassemia, hemophilia, general blood clusters, draining clutters, blood growths and so forth.

Related Conferences:

2nd International Conference on Hematology & Oncology, August 23-25, 2018, London, Uk; 10th World Hematology and Oncology Congress, October 22-24, 2018, Warsaw, Poland;ASH Meeting on Hematologic Malignancies, September 7-8, 2018 Chicago, Illinois; 12th International Conference on Hematology & Hematological Oncology, October 29-30, 2018, San Francisco, California, USA; ASH Meeting on Lymphoma Biology, August 2-5, 2018 Chantilly, Virginia; 12th World Hematology Conferences, March 15-16, 2018, London, UK; The 2nd International Conference on Clinical Trials in Oncology and Hemato-Oncology Conferences, February 19-20, Berlin, Germany; International conference on Stem cell and Tissue Regeneration, Osaka, Japan, June 4-5, 2018; Global Conference on Tissue Engineering and Regenerative medicine, Barcelone, Spain, July 30-31, 2018; World conference on pediatric and Neonatology, Osaka, Japan, July 26-27, 2018; Global Congress on Immunology and Immunotechniques, Chicago, USA, August 20-22, 2018.

Related Associations:

International Society for Laboratory Hematology, The Candian Hematology Society, Michigan Society of Hematology, American Society for oncology, European Society of Hematology, British Society of Hematology, International Society of Hematology, European Society of Pediatric Hematology, Emirates Society of Hematology, Saudi Society for Hematology, Haematology Society of Australia and New Zealand, Malaysian Society of Hematology.

Track 2: Blood Disorders

A blood disorder is any condition that effects at least one sections of the blood, normally meddling with its capacity to work effectively. Many blood disorders take their name from the part of the blood they impact. Blood disorders are conditions that affect the blood's capacity to work accurately. There is a scope of various sorts and side effects rely upon the sort. In any case, some normal side effects incorporate unexplained weakness and weight reduction. Most blood disorders diminish the number of cells, proteins, platelets, or supplements in the blood, or meddle with their capacity. A larger part of the blood issue is caused by transformations in parts of particular qualities and can be passed down in families. Some medical conditions, prescriptions, and way of life elements can likewise cause blood disorder to create.

Related Conferences:

Related Associations:

Track 3: Haematological Oncology

The finding of treatment and counteractive action of blood illnesses (hematology) and malignancy (oncology) and investigation in them. Hematology-oncology incorporates such sicknesses as iron lack paleness, hemophilia, sickle cell illness, the thalassemias, leukemias and lymphomas, and in addition tumors of different organs.

Related Conferences:

Related Associations:

Track 4: Blood Transfusion

This possibly life-sparing method can help supplant blood lost because of medical procedure or damage. A blood transfusion likewise can help if a sickness keeps your body from making blood or a portion of your blood's segments effectively. A blood transfusion is a method for adding blood to your body after a disease or damage. On the off chance that your body is missing at least one of the segments that make up solid blood, a transfusion can help supply what your body is missing. Our blood is comprised of a few unique parts including red and white cells, plasma, and platelets. "Entire blood" alludes to blood that has every one of them. Now and again, you may need a transfusion that utilizations entire blood, yet it's more probable that you'll require a particular segment.

Related Conferences:

Related Associations:

Track 5: Stem cell Research

Stem cells are undifferentiated, or “blank,” cells. This means they’re capable of developing into cells that serve numerous functions in different parts of the body. Most cells in the body are differentiated cells. These cells can only serve a specific purpose in a particular organ. For example, red blood cells are specifically designed to carry oxygen through the blood. All humans start out as only one cell. This cell is called a zygote, or a fertilized egg. The zygote divides into two cells, then four cells, and so on. Eventually, the cells begin to differentiate, taking on a certain function in a part of the body. This process is called differentiation. Stem cells are cells that haven’t differentiated yet. They have the ability to divide and make an indefinite number of copies of themselves. Other cells in the body can only replicate a limited number of times before they begin to break down. When a stem cell divides, it can either remain a stem cell or turn into a differentiated cell, such as a muscle cell or a red blood cell.

Related Conferences:

Related Associations:

Track 6: Blood Tests

Blood tests help doctors check for certain diseases and conditions. They also help check the function of your organs and show how well treatments are working. Specifically, blood tests can help doctors: Evaluate how well organs—such as the kidneys, liver, thyroid, and heart—are working Diagnose diseases and conditions such as cancer, HIV/AIDS, diabetes, anemia (uh-NEE-me-eh), and coronary heart disease Find out whether you have risk factors for heart disease Check whether medicines you're taking are working, Assess how well your blood is clotting.

Related Conferences:

Related Associations:

Track 7: Multiple Myeloma

In multiple myeloma, a type of white blood cell called a plasma cell multiplies unusually. Normally, they make antibodies that fight infections. But in multiple myeloma, they release too much protein (called immunoglobulin) into your bones and blood. It builds up throughout your body and causes organ damage. The plasma cells also crowd normal blood cells in your bones. They release chemicals that trigger other cells to dissolve bone. The weak areas of bone this creates are called lytic lesions. As multiple myeloma gets worse, those plasma cells begin to spill out of your bone marrow and spread through your body. This causes more organ damage.

Related Conferences:

Related Associations:

Track 8: Paediatric Haematology

Pediatric hematology is a branch of Haematology which deals with child or teen who is suffering from Hematologic Disorders. A pediatric hematologist/oncologist is a specialist who treats children and adolescents with blood diseases or cancer. They are specially trained to work with young patients as well as in both hematology (the study of blood) and oncology (the study of cancer) in children. Pediatric hematologist/oncologists are specially trained to treat children with blood disorders and cancer, some of which exclusively appear in the early years of life.

Related Conferences:

Related Associations:

Track 9: Veterinary Haematology

Veterinary hematology is incredibly interesting because there are marked species differences in hematopoietic cells. For instance, birds, amphibians and reptiles have nucleated erythrocytes and platelets (called thrombocytes), which makes an assessment of their blood far more challenging than those of mammals. Species also demonstrate marked variability in the size of their erythrocytes, ranging from cells as small as 19 FL in sheep to as large as 120 FL in elephants. There is less variability in leukocytes and platelets in mammals, but different species do have unique responses to inflammation or immune challenge. Since animals cannot speak for themselves, we use their blood as a window into their bodies. Abnormalities in the blood can provide clues as to the presence of underlying disease (e.g. inflammation) and can be diagnostic in itself, e.g. can reveal a leukemia.

Related Conferences:

Related Associations:

Track 10: Biomarkers in Haematology

Biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker can be used as an indicator of a physiological state or a particular disease of an organism. Biomarkers in haematology are useful to detect or diagnose blood diseases in animals.

Related Conferences:

Related Associations:

Track 11: Hemochromatosis

Hemochromatosis is one of the most common genetic disorders in the United States. It is an inherited condition in which the body absorbs and stores too much iron. The extra iron builds up in several organs, especially the liver, and can cause serious damage. Without treatment, the disease can cause these organs to fail. Iron is an essential nutrient found in many foods. Healthy people usually absorb about 10 percent of the iron contained in the food they eat to meet the body’s needs. People with hemochromatosis absorb more than the body needs. The body has no natural way to rid itself of the excess iron, causing the excess to build up in the organs.

Related Conferences:

Related Associations:

Track 12: Immuno-Hematology

The study of the immunology and genetics of blood groups, blood cell antigens and antibodies, and specific blood proteins (such as complement); esp. important in blood banking and transfusion medicine. Immunohematology is more commonly known as "blood banking". This is the area of laboratory medicine dealing with preparing blood and blood components for transfusion as well as selection of appropriate, compatible components for transfusion. Individuals may become immunized to red blood cells due to previous exposure to red blood cells of other people, most commonly through transfusion or pregnancy. Our children receive immunizations which cause them to form antibodies against the immunizing material, such as tetanus. If they are then exposed to the organism which causes tetanus, the antibodies will destroy them before they can cause infection. In the same way, red blood cells have structures on their surface called antigens. If an individual is transfused with blood or is pregnant with a foetus that possesses structures which the recipient or mother does not have, this may induce the individual to form antibodies. These antibodies may then destroy red blood cells which possess the antigen if additional transfusions are needed. This is why all blood banks will "screen" potential blood recipients for unexpected antibodies and they will then select blood which lacks the offending antigen. The formation of these antibodies is an unusual occurrence, occurring in approximately 0.1-3% of the general population.

Related Conferences:

Related Associations:

Track 13: Haematological Malignancies

Hematologic malignancies have historically been at the vanguard among cancers in the use of genetic analyses for diagnosis, classification, prognostication, and therapeutic decision-making. Genetic characterization is vital in the clinical evaluation of nearly every form of hematologic malignancy and has continuously evolved with increased genomic evaluation of cancer and improvements in molecular diagnostic technologies. Here, we review how genetic analysis contributes to the diagnosis and/or management of acute leukemias, chronic myeloid neoplasms, B- and T-/natural killer (NK)-cell lymphomas, as well as multiple myeloma. We specifically focus on the genetic alterations essential for establishing diagnoses and/or determining standard clinical care.

Related Conferences:

Related Associations:

Track 14: Management of Hematologic Emergencies

The development of hematologic emergencies related to the underlying disease or as a result of complications of therapy is common in hematology practice. These hematologic emergencies can occur as an initial presentation or in a patient with an established diagnosis and are encountered in all medical care settings, ranging from primary care to the emergency department and various subspecialty environments. Therefore, it is critically important that all physicians have a working knowledge of the potential hematologic and oncological emergencies that may present in their practice and how to provide the most effective care without delay. Patients with cancer commonly present with emergent complications of either the malignant disease itself or the therapy they are receiving. Practicing clinicians can, therefore, expect to encounter such patients in emergency departments or outpatient offices. Prompt evaluation and accurate diagnosis followed by the institution of appropriate therapy can be lifesaving and may prevent irreversible loss of organ function. Sound knowledge of oncological and hematologic emergencies is therefore very important for all healthcare professionals involved in direct patient care.

Track 15: New Drug Discovery in Hematology

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics, and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies can “de-risk” early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted, with a focus on hematologic malignancies. In addition, a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry, and non-profit charitable organizations are discussed.

Track 16: Case reports and Epidemiology of Hematology & Hem-Oncology

A case report is usually considered a kind of anecdotal proof. Given their intrinsic method limitations, including the absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, besides case series. However, Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between the administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases, moreover as uncommon presentations of common diseases. They can facilitate generate study hypotheses, as well as plausible mechanisms of disease. Case reports might also have a task to play in guiding the personalization of treatments in clinical follow.

Track 16: Haematology & Oncology Nursing

Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. They may also assist with blood transfusions, blood tests, research, and chemotherapy. If you go into hematology, expect to have more responsibility than other nurses, prescriptive authority, and the ability to order diagnostic lab work. Some of the more commonly-known blood diseases and disorders a Hematology nurse may encounter include Leukemia, lymphoma, sickle cell anemia, and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children i.e. Pediatric Hematology nurses. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research, and chemotherapy. Advanced practice hematology nursing has some prescriptive authority and can also order diagnostic lab work done.

Track 17: Transfusion Medicine and Hematology Research

Transfusion medicine is the branch of medicine that is concerned with the transfusion of blood and blood components. It encompasses issues of blood donation, immunohematology and other laboratory testing, transfusion practices, therapeutic apheresis, stem cell collections, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations related to blood products are also a large part of the field. Blood banking is the process that takes place in the lab to make sure that donated blood or blood products are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases.

Market Analysis:

Medical Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices Medical oncology is an Medical oncologist. Medical Oncology (MO) conveys the effects of clinical and test research in oncology and haematology, especially with trial therapeutics with the field of immunotherapy and chemotherapy. It additionally gives best in class surveys on clinical and test treatments in oncology and haematology. Topics include incorporate immunobiology, pathogenesis, and treatment of dangerous tumors.

Conference Series llc LTD invites all the medical professionals, Medical Oncologists, Haematologists, Immunologists, Pathologists, Oncologists, Research scholars, Industrial Professionals and Student Delegates from Biomedical and healthcare sectors to be a part of the esteemed Blood Disorders 2019. Advanced Diagnostic and therapeutic equipment along with the novel drugs for the cancer & Blood diseases are an integral part of the Oncology & Haematology research, hence it will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

World Haematology Market Report:

North America dominated the global hematology diagnostics market due to increasing blood disorders and aging population. North America hold the largest share of 41.75% in the Global hematology market, which is estimated to be $1810.4 million in 2013, and is expected to reach $2470.05 million by 2018, at a CAGR of 6% from 2013 to 2018.

Europe holds the second larges position in the hematology market. Where Germany commanded the largest share of 20% at $272.8 million in 2013, and is expected to reach $340.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018.

China on the other hand hold the largest share of 53% in the Asian hematology market at $216.0 million in 2013, and is expected to reach $429.1 million by 2018, at a CAGR of 15.4% from

From 2013 to 2018.

Hematology Societies around the world:

American Society of Hematology
British Society for Hematology
Michigan Society of Hematology and Oncology
European Hematology Association(EHA)
Advanced Practitioner Society for Hematology and Oncology
Pennsylvania Society of Oncology and Hematology
Belgian Hematology Society

Haematology Market Study:

The Hematology market in Asia and the middle East is doubling in digits and remains to grown on in the upcoming years. The Americas controlled the huge share of 41.75% of Hematology throughout the worldwide and can be predicted up to $1,810.4 million in 2013, expected to reach $2,479.05 million by 2019, at a CAGR of 6% from 2013 to 2019. Europe is controlling the second largest market share of hematology. Germany is controlling a share of almost 20%. Hematology market in Europe expected to $272.8 million in 2013 and is estimated to grasp over $349.7 million by 2019, at a CAGR of 5.4% from 2013 to 2019. China controlling the largest share of 53% of hematology in Asia and an expected market of $216.0 million in 2013, estimated to earn over $429.1 million by 2019, at a CAGR of 15.4% from 2013 to 2019.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 23-24, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

^{13^th World Congress on} Hematology and Oncology October 23-24, 2019 | Tokyo, Japan

Recommended Global Hematology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

World Hematology 2019

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues